Case studies

Our case studies showcase our work within all phases of drug development. Each case clearly states the challenges and customer needs, and the services and solutions we provided.

Crovalimab-concentration

Crovalimab dose justification based on Phase 3 data in paroxysomal nocturnal hemoglobinurea patients

See this case on Crovalimab dose justication
ketamine-PKPD-modelschematic-1

Assessment of the probability of a drug asset to exceed the target efficacy value in major depression disorder trials using literature data of ketamine and esketamine

See this case on assessment of probabilty
Estimated-monthly-patch-sizes

Model-informed microarray patches design for anti-retroviral drugs to treat children with HIV

See this case on microarray patches design
Car-T-Cell-Illustration-Web

Optimizing CAR-T cell exposure

In absence of clear dose-exposure relationships, there is a need to find other means to optimize CAR-T cell exposure.

See this case on CAR-T cell exposure